Generare
generare.bio
Actively hiring
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
Generare raises €20 million to enhance drug discovery compound library
Generare raises €20 million to enhance drug discovery compound library
Read more
Report
Generare: €20 Million Raised For Techbio Platform Unlocking Novel Drug Molecules
Paris-based techbio company Generare has raised €20 million in a Series A funding round co-led by Alven and Daphni, with participation from existing investors including Galion.exe, Teampact Ventures and VIVES Partners. Founded in 2023, the company is focu
Read more
Report
Generare.bio lève 5 millions d'euros pour découvrir des médicaments grâce à l'ADN microbien
La biotech parisienne Generare.bio annonce avoir levé 5 millions d'euros pour accélérer le développement de sa plateforme de biosynthèse et de clonage,
Read more
Report
Frenchbiotech Generare speeds up hunt for new drugs by cloning natural molecules
French biotech startup Generare has closed a €5 million seed round (around $5.5 million at current exchange rates) to step up development of what it touts as a highly scalable approach to identifying promising compounds for drug discovery that already exi
Read more
Report